Ciaran Scallan

1.1k total citations
15 papers, 534 citations indexed

About

Ciaran Scallan is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ciaran Scallan has authored 15 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 5 papers in Physiology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ciaran Scallan's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Sarcoidosis and Beryllium Toxicity Research (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). Ciaran Scallan is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Sarcoidosis and Beryllium Toxicity Research (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). Ciaran Scallan collaborates with scholars based in Canada, United States and United Kingdom. Ciaran Scallan's co-authors include Carlos A. Morillo, Martin O’Donnell, Zahira Khalid, Robert J. Doonan, Stella S. Daskalopoulou, Dimitri P. Mikhailidis, Anaïs Hausvater, Louise Pilote, Martin Kolb and Dena Zeraatkar and has published in prestigious journals such as Stroke, European Respiratory Journal and Thorax.

In The Last Decade

Ciaran Scallan

15 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ciaran Scallan Canada	8	339	165	123	66	49	15	534
Hasan Ali Gümrükçüoğlu Türkiye	13	299 0.9×	109 0.7×	70 0.6×	55 0.8×	81 1.7×	65	511
Severo Torres Portugal	13	342 1.0×	107 0.6×	101 0.8×	50 0.8×	129 2.6×	91	464
Romeu Sérgio Meneghelo Brazil	10	200 0.6×	64 0.4×	44 0.4×	69 1.0×	46 0.9×	37	369
Dimitris Syrseloudis Greece	12	373 1.1×	57 0.3×	40 0.3×	80 1.2×	79 1.6×	24	491
Ilaria Dentamaro Italy	10	186 0.5×	112 0.7×	48 0.4×	18 0.3×	41 0.8×	39	395
Athanasios Manginas Greece	10	251 0.7×	215 1.3×	110 0.9×	63 1.0×	125 2.6×	29	434
Shu‐Man Lin Taiwan	13	129 0.4×	86 0.5×	110 0.9×	36 0.5×	79 1.6×	31	431
Jacques Mansourati France	12	586 1.7×	37 0.2×	90 0.7×	95 1.4×	126 2.6×	46	716
Harvinder S. Dod United States	13	438 1.3×	214 1.3×	291 2.4×	140 2.1×	182 3.7×	36	687
Vegard Malmo Norway	13	487 1.4×	41 0.2×	37 0.3×	31 0.5×	34 0.7×	23	601

Countries citing papers authored by Ciaran Scallan

Since Specialization

Citations

This map shows the geographic impact of Ciaran Scallan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ciaran Scallan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ciaran Scallan more than expected).

Fields of papers citing papers by Ciaran Scallan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ciaran Scallan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ciaran Scallan. The network helps show where Ciaran Scallan may publish in the future.

Co-authorship network of co-authors of Ciaran Scallan

This figure shows the co-authorship network connecting the top 25 collaborators of Ciaran Scallan. A scholar is included among the top collaborators of Ciaran Scallan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ciaran Scallan. Ciaran Scallan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Macisaac, S., et al.. (2024). Treatment of idiopathic pulmonary fibrosis: an update on emerging drugs in phase II & III clinical trials. Expert Opinion on Emerging Drugs. 29(2). 177–186. 7 indexed citations

Pitre, Tyler, Jasmine Mah, Johnny Su, et al.. (2022). Medical treatments for idiopathic pulmonary fibrosis: a systematic review and network meta-analysis. Thorax. 77(12). 1243–1250. 46 indexed citations

Pitre, Tyler, Jasmine Mah, Johnny Su, et al.. (2022). Sildenafil for idiopathic pulmonary fibrosis: A systematic review and meta-analysis. Pulmonary Pharmacology & Therapeutics. 73-74. 102128–102128. 5 indexed citations

Yanagihara, Toyoshi, Ciaran Scallan, Kjetil Ask, & Martin Kolb. (2021). Emerging therapeutic targets for idiopathic pulmonary fibrosis: preclinical progress and therapeutic implications. Expert Opinion on Therapeutic Targets. 25(11). 939–948. 7 indexed citations

Scallan, Ciaran, Jennifer Hayes, Suha Kadura, et al.. (2021). R-scale for pulmonary fibrosis: a simple, visual tool for the assessment of health-related quality of life. European Respiratory Journal. 59(1). 2100917–2100917. 11 indexed citations

Chong, Sy Giin, et al.. (2021). Sarcoidosis and Tuberculosis: A Case Report and Literature Review. 0(0). 0–0. 1 indexed citations

Ho, Terence, Ciaran Scallan, Nathan Hambly, et al.. (2020). Sputum quantitative cytometry in patients with interstitial lung disease and chronic cough. Respiratory Medicine. 170. 106067–106067. 1 indexed citations

Scallan, Ciaran, et al.. (2020). Progressive fibrosing interstitial lung disease: treatable traits and therapeutic strategies. Current Opinion in Pulmonary Medicine. 26(5). 436–442. 14 indexed citations

Scallan, Ciaran, Bridget F. Collins, & Ganesh Raghu. (2020). Systemic sclerosis-associated interstitial lung disease. Current Opinion in Pulmonary Medicine. 26(5). 487–495. 5 indexed citations

10.

Sullivan, Catherine, et al.. (2016). Is Signature Size Associated With Organ Donor Designation on Driver's Licenses?. Transplantation Proceedings. 48(6). 1911–1915. 1 indexed citations

11.

Iqbal, Muhammad Nouman, Anne M. Huml, Vidya Krishnan, et al.. (2016). What’s in a Name? Factors Associated with Documentation and Evaluation of Incidental Pulmonary Nodules. Annals of the American Thoracic Society. 13(10). 1704–1711. 8 indexed citations

12.

Scallan, Ciaran, et al.. (2015). The Relationship Between Verified Organ Donor Designation and Patient Demographic and Medical Characteristics. American Journal of Transplantation. 16(4). 1294–1297. 19 indexed citations

13.

Doonan, Robert J., Anaïs Hausvater, Ciaran Scallan, et al.. (2010). The effect of smoking on arterial stiffness. Hypertension Research. 33(5). 398–410. 152 indexed citations

14.

Scallan, Ciaran, Robert J. Doonan, & Stella S. Daskalopoulou. (2010). The Combined Effect of Hypertension and Smoking on Arterial Stiffness. Clinical and Experimental Hypertension. 32(6). 319–328. 13 indexed citations

15.

Khalid, Zahira, et al.. (2007). Noninvasive Cardiac Monitoring for Detecting Paroxysmal Atrial Fibrillation or Flutter After Acute Ischemic Stroke. Stroke. 38(11). 2935–2940. 244 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact